Active, Not Recruiting
Phase II Trial of Pembrolizumab in Recurrent or Metastatic HNSCC
NCT03813836
- Conditions
- Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +7 more
- Locations
-
- Aberdeen Royal Infirmary (NHS Grampian) Aberdeen, United Kingdom
- Bristol Haematology and Oncology Centre (University Hospital Bristol NHS Foundation Trust) Bristol, United Kingdom
- Western General Hospital (NHS Lothian) Edinburgh, United Kingdom
- East Suffolk and North Essex NHS Foundation Trust Ipswich, United Kingdom